Deferred Tax Assets, Valuation Allowance of Protagenic Therapeutics, Inc.\new from 30 Jun 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protagenic Therapeutics, Inc.\new quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2013 to 31 Dec 2024.
  • Protagenic Therapeutics, Inc.\new Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $8,713,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Protagenic Therapeutics, Inc.\new Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $8,713,000 +$1,642,000 +23% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $7,071,000 +$1,513,000 +27% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $5,558,000 +$137,000 +2.5% 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q4 2021 $5,421,000 +$1,300,000 +32% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $4,121,000 +$418,000 +11% 31 Dec 2020 10-K 07 Apr 2022 2021 FY
Q4 2019 $3,703,000 +$661,000 +22% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $3,042,000 +$279,000 +10% 31 Dec 2018 10-K 29 Apr 2020 2019 FY
Q4 2017 $2,763,000 +$243,000 +9.6% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q4 2016 $2,520,000 +$1,148,000 +84% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $1,372,000 +$445,000 +48% 31 Dec 2015 10-K/A 08 May 2017 2016 FY
Q2 2015 $21,994,000 +$171,000 +0.78% 30 Jun 2015 10-K 25 Sep 2015 2015 FY
Q4 2014 $927,000 31 Dec 2014 8-K/A 12 Jul 2016 2015 FY
Q2 2014 $21,823,000 -$604,000 -2.7% 30 Jun 2014 10-K 25 Sep 2015 2015 FY
Q2 2013 $22,427,000 30 Jun 2013 10-K 14 Oct 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.